Literature DB >> 7698843

Occurrence of verotoxin (Shiga-like toxin) producing Escherichia coli in human urinary tract infection.

L Beutin, H Karch, S Aleksić, F B Spencker, U Rosenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7698843     DOI： 10.1007/bf01715504

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  2 in total

1.  Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin.

Authors:  T Takao; T Tanabe; Y M Hong; Y Shimonishi; H Kurazono; T Yutsudo; C Sasakawa; M Yoshikawa; Y Takeda
Journal:  Microb Pathog       Date:  1988-11       Impact factor: 3.738

Review 2.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132
  2 in total
  4 in total

1.  Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Authors:  Francisco Toval; Roswitha Schiller; Iris Meisen; Johannes Putze; Ivan U Kouzel; Wenlan Zhang; Helge Karch; Martina Bielaszewska; Michael Mormann; Johannes Müthing; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin.

Authors:  James R Johnson; Catherine Jerome; Daniel R Boster; Ann E Stapleton; Phillip I Tarr
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.

Authors:  Francisco Toval; Christian-Daniel Köhler; Ulrich Vogel; Florian Wagenlehner; Alexander Mellmann; Angelika Fruth; M Alexander Schmidt; Helge Karch; Martina Bielaszewska; Ulrich Dobrindt
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

Review 4.  Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases.

Authors:  Ana Carolina de Mello Santos; Fernanda Fernandes Santos; Rosa Maria Silva; Tânia Aparecida Tardelli Gomes
Journal:  Front Cell Infect Microbiol       Date:  2020-07-15       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.